Literature DB >> 16185343

Synthetic vascular prosthesis impregnated with genetically modified bone marrow cells produced recombinant proteins.

Sachiko Kanki-Horimoto1, Hitoshi Horimoto, Shigetoshi Mieno, Kenji Kishida, Fusao Watanabe, Eisuke Furuya, Takahiro Katsumata.   

Abstract

The aim of this study is to develop an experimental model of small caliber expanded polytetrafluoroethylene (ePTFE) vascular prostheses that produce recombinant proteins by seeding genetically modified bone marrow mesenchymal stem cells (MSC). Beta-galactosidase (beta-gal) cDNA was transduced into rat MSC mediated by an adenovirus vector. The cells were impregnated into the ePTFE vascular prostheses measuring 2 mm in internal diameter and 90 microm in fibril length, followed by 48 h of incubation. The expressions of beta-gal were determined by X-gal staining. The luminal surface of the ePTFE vascular prostheses was covered with the MSC expressing beta-gal. Most of the gene-transduced MSC spread along the fibers forming colonies. These results suggest that small caliber vascular prostheses, in which the inner surface was seeded by genetically modified MSC, produced recombinant proteins. This may be a preliminary model to autocrine functioning vascular prostheses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16185343     DOI: 10.1111/j.1525-1594.2005.00134.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  1 in total

1.  The healing of critical-size calvarial bone defects in rat with rhPDGF-BB, BMSCs, and β-TCP scaffolds.

Authors:  Ling Xu; Kaige Lv; Wenjie Zhang; Xiuli Zhang; Xinquan Jiang; Fuqiang Zhang
Journal:  J Mater Sci Mater Med       Date:  2012-02-07       Impact factor: 3.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.